Lactobacillus Kefiri LKF01 (Kefibios(®)) for Prevention of Diarrhoea in Cancer Patients Treated with Chemotherapy: A Prospective Study

Diarrhoea is one of the main side effects that cancer patients face. The literature showsthat the incidence of chemotherapy (CT)-induced diarrhoea (grade 3–4) in treated patients is in the range of 10–20%, particularly after 5-fluorouracil (5-FU) bolus or some combination therapies of irinotecan and...

Descripción completa

Detalles Bibliográficos
Autores principales: Ghidini, Michele, Nicoletti, Mariaceleste, Ratti, Margherita, Tomasello, Gianluca, Lonati, Veronica, Ghilardi, Mara, Parati, Maria Chiara, Borgonovo, Karen, Cabiddu, Mary, Petrelli, Fausto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7912053/
https://www.ncbi.nlm.nih.gov/pubmed/33513713
http://dx.doi.org/10.3390/nu13020385

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7912053/
https://www.ncbi.nlm.nih.gov/pubmed/33513713
http://dx.doi.org/10.3390/nu13020385

Ejemplares similares